Inventor · disambiguated record
Andrej Jancarik
Also filed as: JANCARIK ANDREJ
12 granted patents·34 citations·filing 2015–2022
88Inventor score
Files withUNIV JOHNS HOPKINS12
Top patents by PatentIndex Score
12 records- 0194US10738066B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2019·Granted Aug 11, 2020·5 cites·18 claims
- 0294US10336778B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2018·Granted Jul 2, 2019·8 cites·4 claims
- 0393US10954257B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2019·Granted Mar 23, 2021·4 cites·19 claims
- 0491US9988407B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2015·Granted Jun 5, 2018·11 cites·11 claims
- 0589US11325931B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2020·Granted May 10, 2022·2 cites·19 claims
- 0683US11059775B2Prodrug compositions and utility of hydroxamate-based GCPII inhibitorsUNIV JOHNS HOPKINS·Filed 2017·Granted Jul 13, 2021·2 cites·1 claims
- 0780US10544176B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2018·Granted Jan 28, 2020·2 cites·4 claims
- 0878US11932664B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2022·Granted Mar 19, 2024·0 cites·9 claims
- 0975US11926640B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2021·Granted Mar 12, 2024·0 cites·16 claims
- 1073US11866394B2Prodrugs of hydroxamate-based GCPII inhibitorsUNIV JOHNS HOPKINS·Filed 2021·Granted Jan 9, 2024·0 cites·3 claims
- 1166US11759444B2Methods for cancer and immunotherapy using prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2020·Granted Sep 19, 2023·0 cites·19 claims
- 1250US11712435B2Mebendazole prodrugs with enhanced solubility and oral bioavailabilityUNIV JOHNS HOPKINS·Filed 2019·Granted Aug 1, 2023·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Andrej Jancarik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →